Trial NCT05516849

View at ClinicalTrials.gov 
Org. Study IDs: 3822: POST-INJURY

Last trial update was posted on 2023-08-14

MeSH Interventions

Oxandrolone

MeSH Conditions

Wounds and Injuries

Other Conditions

Trauma Injury

Stopping Reasons

FDA requested manufacturers of Oxandrolone Tablets, to voluntarily remove previously approved drug applications for Oxandrolone from the U.S. market & the funding decided to prematurely terminate the funding.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID